SRX23795819 GSM8119811_r1 SRP492601 PRJNA1082303 SRS20618870 GSM8119811 GSM8119811 RNA-Seq TRANSCRIPTOMIC cDNA CM-treated cells were lysed and RNA extracted using RNeasy Kit (Qiagen). Total RNA from quintuple samples was sequenced by the Center for Cancer Research Sequencing Facility (Bethesda, MD) using an Illumina HiSeq 2500 instrument. Illumina HiSeq 2500 SRX23795820 GSM8119812_r1 SRP492601 PRJNA1082303 SRS20618871 GSM8119812 GSM8119812 RNA-Seq TRANSCRIPTOMIC cDNA CM-treated cells were lysed and RNA extracted using RNeasy Kit (Qiagen). Total RNA from quintuple samples was sequenced by the Center for Cancer Research Sequencing Facility (Bethesda, MD) using an Illumina HiSeq 2500 instrument. Illumina HiSeq 2500 SRX23795821 GSM8119813_r1 SRP492601 PRJNA1082303 SRS20618872 GSM8119813 GSM8119813 RNA-Seq TRANSCRIPTOMIC cDNA CM-treated cells were lysed and RNA extracted using RNeasy Kit (Qiagen). Total RNA from quintuple samples was sequenced by the Center for Cancer Research Sequencing Facility (Bethesda, MD) using an Illumina HiSeq 2500 instrument. Illumina HiSeq 2500 SRX23795822 GSM8119814_r1 SRP492601 PRJNA1082303 SRS20618873 GSM8119814 GSM8119814 RNA-Seq TRANSCRIPTOMIC cDNA CM-treated cells were lysed and RNA extracted using RNeasy Kit (Qiagen). Total RNA from quintuple samples was sequenced by the Center for Cancer Research Sequencing Facility (Bethesda, MD) using an Illumina HiSeq 2500 instrument. Illumina HiSeq 2500 SRX23795823 GSM8119815_r1 SRP492601 PRJNA1082303 SRS20618874 GSM8119815 GSM8119815 RNA-Seq TRANSCRIPTOMIC cDNA CM-treated cells were lysed and RNA extracted using RNeasy Kit (Qiagen). Total RNA from quintuple samples was sequenced by the Center for Cancer Research Sequencing Facility (Bethesda, MD) using an Illumina HiSeq 2500 instrument. Illumina HiSeq 2500 SRX23795824 GSM8119816_r1 SRP492601 PRJNA1082303 SRS20618875 GSM8119816 GSM8119816 RNA-Seq TRANSCRIPTOMIC cDNA CM-treated cells were lysed and RNA extracted using RNeasy Kit (Qiagen). Total RNA from quintuple samples was sequenced by the Center for Cancer Research Sequencing Facility (Bethesda, MD) using an Illumina HiSeq 2500 instrument. Illumina HiSeq 2500 SRX23795825 GSM8119817_r1 SRP492601 PRJNA1082303 SRS20618876 GSM8119817 GSM8119817 RNA-Seq TRANSCRIPTOMIC cDNA CM-treated cells were lysed and RNA extracted using RNeasy Kit (Qiagen). Total RNA from quintuple samples was sequenced by the Center for Cancer Research Sequencing Facility (Bethesda, MD) using an Illumina HiSeq 2500 instrument. Illumina HiSeq 2500 SRX23795826 GSM8119818_r1 SRP492601 PRJNA1082303 SRS20618877 GSM8119818 GSM8119818 RNA-Seq TRANSCRIPTOMIC cDNA CM-treated cells were lysed and RNA extracted using RNeasy Kit (Qiagen). Total RNA from quintuple samples was sequenced by the Center for Cancer Research Sequencing Facility (Bethesda, MD) using an Illumina HiSeq 2500 instrument. Illumina HiSeq 2500 SRX23795827 GSM8119819_r1 SRP492601 PRJNA1082303 SRS20618878 GSM8119819 GSM8119819 RNA-Seq TRANSCRIPTOMIC cDNA CM-treated cells were lysed and RNA extracted using RNeasy Kit (Qiagen). Total RNA from quintuple samples was sequenced by the Center for Cancer Research Sequencing Facility (Bethesda, MD) using an Illumina HiSeq 2500 instrument. Illumina HiSeq 2500 SRX23795828 GSM8119820_r1 SRP492601 PRJNA1082303 SRS20618879 GSM8119820 GSM8119820 RNA-Seq TRANSCRIPTOMIC cDNA CM-treated cells were lysed and RNA extracted using RNeasy Kit (Qiagen). Total RNA from quintuple samples was sequenced by the Center for Cancer Research Sequencing Facility (Bethesda, MD) using an Illumina HiSeq 2500 instrument. Illumina HiSeq 2500 SRX23795829 GSM8119821_r1 SRP492601 PRJNA1082303 SRS20618880 GSM8119821 GSM8119821 RNA-Seq TRANSCRIPTOMIC cDNA CM-treated cells were lysed and RNA extracted using RNeasy Kit (Qiagen). Total RNA from quintuple samples was sequenced by the Center for Cancer Research Sequencing Facility (Bethesda, MD) using an Illumina HiSeq 2500 instrument. Illumina HiSeq 2500 SRX23795830 GSM8119822_r1 SRP492601 PRJNA1082303 SRS20618881 GSM8119822 GSM8119822 RNA-Seq TRANSCRIPTOMIC cDNA CM-treated cells were lysed and RNA extracted using RNeasy Kit (Qiagen). Total RNA from quintuple samples was sequenced by the Center for Cancer Research Sequencing Facility (Bethesda, MD) using an Illumina HiSeq 2500 instrument. Illumina HiSeq 2500 SRX23795831 GSM8119823_r1 SRP492601 PRJNA1082303 SRS20618882 GSM8119823 GSM8119823 RNA-Seq TRANSCRIPTOMIC cDNA CM-treated cells were lysed and RNA extracted using RNeasy Kit (Qiagen). Total RNA from quintuple samples was sequenced by the Center for Cancer Research Sequencing Facility (Bethesda, MD) using an Illumina HiSeq 2500 instrument. Illumina HiSeq 2500 SRX23795832 GSM8119824_r1 SRP492601 PRJNA1082303 SRS20618883 GSM8119824 GSM8119824 RNA-Seq TRANSCRIPTOMIC cDNA CM-treated cells were lysed and RNA extracted using RNeasy Kit (Qiagen). Total RNA from quintuple samples was sequenced by the Center for Cancer Research Sequencing Facility (Bethesda, MD) using an Illumina HiSeq 2500 instrument. Illumina HiSeq 2500 SRX23795833 GSM8119825_r1 SRP492601 PRJNA1082303 SRS20618884 GSM8119825 GSM8119825 RNA-Seq TRANSCRIPTOMIC cDNA CM-treated cells were lysed and RNA extracted using RNeasy Kit (Qiagen). Total RNA from quintuple samples was sequenced by the Center for Cancer Research Sequencing Facility (Bethesda, MD) using an Illumina HiSeq 2500 instrument. Illumina HiSeq 2500 SRX23795834 GSM8119826_r1 SRP492601 PRJNA1082303 SRS20618885 GSM8119826 GSM8119826 RNA-Seq TRANSCRIPTOMIC cDNA CM-treated cells were lysed and RNA extracted using RNeasy Kit (Qiagen). Total RNA from quintuple samples was sequenced by the Center for Cancer Research Sequencing Facility (Bethesda, MD) using an Illumina HiSeq 2500 instrument. Illumina HiSeq 2500 SRX23795835 GSM8119827_r1 SRP492601 PRJNA1082303 SRS20618886 GSM8119827 GSM8119827 RNA-Seq TRANSCRIPTOMIC cDNA CM-treated cells were lysed and RNA extracted using RNeasy Kit (Qiagen). Total RNA from quintuple samples was sequenced by the Center for Cancer Research Sequencing Facility (Bethesda, MD) using an Illumina HiSeq 2500 instrument. Illumina HiSeq 2500 SRX23795836 GSM8119828_r1 SRP492601 PRJNA1082303 SRS20618887 GSM8119828 GSM8119828 RNA-Seq TRANSCRIPTOMIC cDNA CM-treated cells were lysed and RNA extracted using RNeasy Kit (Qiagen). Total RNA from quintuple samples was sequenced by the Center for Cancer Research Sequencing Facility (Bethesda, MD) using an Illumina HiSeq 2500 instrument. Illumina HiSeq 2500 SRX23795837 GSM8119829_r1 SRP492601 PRJNA1082303 SRS20618888 GSM8119829 GSM8119829 RNA-Seq TRANSCRIPTOMIC cDNA CM-treated cells were lysed and RNA extracted using RNeasy Kit (Qiagen). Total RNA from quintuple samples was sequenced by the Center for Cancer Research Sequencing Facility (Bethesda, MD) using an Illumina HiSeq 2500 instrument. Illumina HiSeq 2500 SRX23795838 GSM8119830_r1 SRP492601 PRJNA1082303 SRS20618889 GSM8119830 GSM8119830 RNA-Seq TRANSCRIPTOMIC cDNA CM-treated cells were lysed and RNA extracted using RNeasy Kit (Qiagen). Total RNA from quintuple samples was sequenced by the Center for Cancer Research Sequencing Facility (Bethesda, MD) using an Illumina HiSeq 2500 instrument. Illumina HiSeq 2500 SRX23795839 GSM8119831_r1 SRP492601 PRJNA1082303 SRS20618890 GSM8119831 GSM8119831 RNA-Seq TRANSCRIPTOMIC cDNA CM-treated cells were lysed and RNA extracted using RNeasy Kit (Qiagen). Total RNA from quintuple samples was sequenced by the Center for Cancer Research Sequencing Facility (Bethesda, MD) using an Illumina HiSeq 2500 instrument. Illumina HiSeq 2500 SRX23795840 GSM8119832_r1 SRP492601 PRJNA1082303 SRS20618891 GSM8119832 GSM8119832 RNA-Seq TRANSCRIPTOMIC cDNA CM-treated cells were lysed and RNA extracted using RNeasy Kit (Qiagen). Total RNA from quintuple samples was sequenced by the Center for Cancer Research Sequencing Facility (Bethesda, MD) using an Illumina HiSeq 2500 instrument. Illumina HiSeq 2500 SRX23795841 GSM8119833_r1 SRP492601 PRJNA1082303 SRS20618892 GSM8119833 GSM8119833 RNA-Seq TRANSCRIPTOMIC cDNA CM-treated cells were lysed and RNA extracted using RNeasy Kit (Qiagen). Total RNA from quintuple samples was sequenced by the Center for Cancer Research Sequencing Facility (Bethesda, MD) using an Illumina HiSeq 2500 instrument. Illumina HiSeq 2500 SRX23795842 GSM8119834_r1 SRP492601 PRJNA1082303 SRS20618893 GSM8119834 GSM8119834 RNA-Seq TRANSCRIPTOMIC cDNA CM-treated cells were lysed and RNA extracted using RNeasy Kit (Qiagen). Total RNA from quintuple samples was sequenced by the Center for Cancer Research Sequencing Facility (Bethesda, MD) using an Illumina HiSeq 2500 instrument. Illumina HiSeq 2500 SRX23795843 GSM8119835_r1 SRP492601 PRJNA1082303 SRS20618894 GSM8119835 GSM8119835 RNA-Seq TRANSCRIPTOMIC cDNA CM-treated cells were lysed and RNA extracted using RNeasy Kit (Qiagen). Total RNA from quintuple samples was sequenced by the Center for Cancer Research Sequencing Facility (Bethesda, MD) using an Illumina HiSeq 2500 instrument. Illumina HiSeq 2500 SRX23795844 GSM8119836_r1 SRP492601 PRJNA1082303 SRS20618895 GSM8119836 GSM8119836 RNA-Seq TRANSCRIPTOMIC cDNA CM-treated cells were lysed and RNA extracted using RNeasy Kit (Qiagen). Total RNA from quintuple samples was sequenced by the Center for Cancer Research Sequencing Facility (Bethesda, MD) using an Illumina HiSeq 2500 instrument. Illumina HiSeq 2500 SRX23795845 GSM8119837_r1 SRP492601 PRJNA1082303 SRS20618896 GSM8119837 GSM8119837 RNA-Seq TRANSCRIPTOMIC cDNA CM-treated cells were lysed and RNA extracted using RNeasy Kit (Qiagen). Total RNA from quintuple samples was sequenced by the Center for Cancer Research Sequencing Facility (Bethesda, MD) using an Illumina HiSeq 2500 instrument. Illumina HiSeq 2500 SRX23795846 GSM8119838_r1 SRP492601 PRJNA1082303 SRS20618897 GSM8119838 GSM8119838 RNA-Seq TRANSCRIPTOMIC cDNA CM-treated cells were lysed and RNA extracted using RNeasy Kit (Qiagen). Total RNA from quintuple samples was sequenced by the Center for Cancer Research Sequencing Facility (Bethesda, MD) using an Illumina HiSeq 2500 instrument. Illumina HiSeq 2500 SRX23795847 GSM8119839_r1 SRP492601 PRJNA1082303 SRS20618898 GSM8119839 GSM8119839 RNA-Seq TRANSCRIPTOMIC cDNA CM-treated cells were lysed and RNA extracted using RNeasy Kit (Qiagen). Total RNA from quintuple samples was sequenced by the Center for Cancer Research Sequencing Facility (Bethesda, MD) using an Illumina HiSeq 2500 instrument. Illumina HiSeq 2500 SRX23795848 GSM8119840_r1 SRP492601 PRJNA1082303 SRS20618899 GSM8119840 GSM8119840 RNA-Seq TRANSCRIPTOMIC cDNA CM-treated cells were lysed and RNA extracted using RNeasy Kit (Qiagen). Total RNA from quintuple samples was sequenced by the Center for Cancer Research Sequencing Facility (Bethesda, MD) using an Illumina HiSeq 2500 instrument. Illumina HiSeq 2500 SRX23795849 GSM8119841_r1 SRP492601 PRJNA1082303 SRS20618900 GSM8119841 GSM8119841 RNA-Seq TRANSCRIPTOMIC cDNA CM-treated cells were lysed and RNA extracted using RNeasy Kit (Qiagen). Total RNA from quintuple samples was sequenced by the Center for Cancer Research Sequencing Facility (Bethesda, MD) using an Illumina HiSeq 2500 instrument. Illumina HiSeq 2500 SRX23795850 GSM8119842_r1 SRP492601 PRJNA1082303 SRS20618901 GSM8119842 GSM8119842 RNA-Seq TRANSCRIPTOMIC cDNA CM-treated cells were lysed and RNA extracted using RNeasy Kit (Qiagen). Total RNA from quintuple samples was sequenced by the Center for Cancer Research Sequencing Facility (Bethesda, MD) using an Illumina HiSeq 2500 instrument. Illumina HiSeq 2500 SRX23795851 GSM8119843_r1 SRP492601 PRJNA1082303 SRS20618902 GSM8119843 GSM8119843 RNA-Seq TRANSCRIPTOMIC cDNA CM-treated cells were lysed and RNA extracted using RNeasy Kit (Qiagen). Total RNA from quintuple samples was sequenced by the Center for Cancer Research Sequencing Facility (Bethesda, MD) using an Illumina HiSeq 2500 instrument. Illumina HiSeq 2500 SRX23795852 GSM8119844_r1 SRP492601 PRJNA1082303 SRS20618903 GSM8119844 GSM8119844 RNA-Seq TRANSCRIPTOMIC cDNA CM-treated cells were lysed and RNA extracted using RNeasy Kit (Qiagen). Total RNA from quintuple samples was sequenced by the Center for Cancer Research Sequencing Facility (Bethesda, MD) using an Illumina HiSeq 2500 instrument. Illumina HiSeq 2500 SRX23795853 GSM8119845_r1 SRP492601 PRJNA1082303 SRS20618904 GSM8119845 GSM8119845 RNA-Seq TRANSCRIPTOMIC cDNA CM-treated cells were lysed and RNA extracted using RNeasy Kit (Qiagen). Total RNA from quintuple samples was sequenced by the Center for Cancer Research Sequencing Facility (Bethesda, MD) using an Illumina HiSeq 2500 instrument. Illumina HiSeq 2500 SRX23795854 GSM8119846_r1 SRP492601 PRJNA1082303 SRS20618905 GSM8119846 GSM8119846 RNA-Seq TRANSCRIPTOMIC cDNA CM-treated cells were lysed and RNA extracted using RNeasy Kit (Qiagen). Total RNA from quintuple samples was sequenced by the Center for Cancer Research Sequencing Facility (Bethesda, MD) using an Illumina HiSeq 2500 instrument. Illumina HiSeq 2500 SRX23795855 GSM8119847_r1 SRP492601 PRJNA1082303 SRS20618906 GSM8119847 GSM8119847 RNA-Seq TRANSCRIPTOMIC cDNA CM-treated cells were lysed and RNA extracted using RNeasy Kit (Qiagen). Total RNA from quintuple samples was sequenced by the Center for Cancer Research Sequencing Facility (Bethesda, MD) using an Illumina HiSeq 2500 instrument. Illumina HiSeq 2500 SRX23795856 GSM8119848_r1 SRP492601 PRJNA1082303 SRS20618907 GSM8119848 GSM8119848 RNA-Seq TRANSCRIPTOMIC cDNA CM-treated cells were lysed and RNA extracted using RNeasy Kit (Qiagen). Total RNA from quintuple samples was sequenced by the Center for Cancer Research Sequencing Facility (Bethesda, MD) using an Illumina HiSeq 2500 instrument. Illumina HiSeq 2500 SRX23795857 GSM8119849_r1 SRP492601 PRJNA1082303 SRS20618908 GSM8119849 GSM8119849 RNA-Seq TRANSCRIPTOMIC cDNA CM-treated cells were lysed and RNA extracted using RNeasy Kit (Qiagen). Total RNA from quintuple samples was sequenced by the Center for Cancer Research Sequencing Facility (Bethesda, MD) using an Illumina HiSeq 2500 instrument. Illumina HiSeq 2500